How Patient Diversity Challenges Can Be Handled In The Clinical Development Process?

By Author: Biso Health Group
Total Articles: 1
Comment this article

Clinical trials are very important for finding new treatments for diseases. It also helps in diagnosing, reducing, and detecting the chances of developing a disease. Clinical trials should be executed systematically to understand what works or doesn't work on humans. This cannot be learned on animals or in laboratories. It has to be done on humans but there are challenges like patient diversity.

Why is it a challenge?

Enrollment targets are difficult to meet and 25% of clinical trials are at a halt because recruiting enough patients is a challenge. In clinical studies, patient recruitment is a very big challenge and this is because of the lagging diversity in the clinical trials. Nearly 39% of the US population are minorities and hardly seven percent of minorities participate in clinical trials. Native American participation in clinical trials is absent and there is a lack of patient diversity. A very recent study of trials was done across 29 countries and in the last 21 years, 86% of participants were Caucasian.

For clinical trials, patient diversity is an important aspect because it helps everyone. ...
... If the trials are overrepresented by Caucasians then it may lack the required data on necessary differences in patients. This is a vital aspect because in a few cases medicines affect people differently according to their age, sex, race, and various other factors. On the other hand FDA, a regulatory body recommends that there should be adequate representation of the population. In the USA there are various historic reasons for the lack of clinical trial diversity like lack of trust and it happened because of some famed trials on the minorities.

Ways to overcome such challenges for clinical trial diversity are:

Employing technology, site preparation, and clinical trial awareness can help in working with clinical trial sponsors and pharmaceutical consultants to review the protocol for optimization and pre-identify the patients leveraging technology like EHR and various data sources. They help in reviewing the site and assessment and offer preparation and education for the sites in minority communities.

They work with minority-led clinical sites and access the database in minority communities. They have access to more than 500 sites. They also use social media outreach strategy to identify the patients for pre-screening and also take care of their bookings, accommodations, visa for country travel, and many concierges’ needs.

Running clinical trials is an orchestrated process and for clinical development trials, pharmaceutical consultants partner with biopharmaceutical and biotech companies to reinforce patient safety and access throughout every phase of research. Thus, you get quality data to drive promising compounds further.

You can run clinical trials quickly in the most effective way as they implement the best clinical development strategies for achieving your goals.

Conclusion: To improve world-class clinical trial capacity you can get in touch with https://www.bioshealthgroup.com/ as they are focused on using data and technology to improve trial recruitment and hence clinical trial options in all the communities can improve. They are committed to operational excellence in the drug development process and this will work to your advantage. For great results and satisfaction get in touch with them today.

Bios Health Group (BHG) provides solutions like a consultative approach to deliver tailored strategies to fulfill some of the essential needs faced by Biopharmaceutical and Healthcare companies. We offer our services to Small to Mid-Sized Biotechnology Companies, Large and Established Pharmaceutical Companies, Medical Devices, and Other Health-Related Companies.